Development and application

  • 文章类型: Journal Article
    肿瘤免疫治疗领域取得了重大进展,导致出现了许多生物候选药物,需要进行体内功效测试并更好地了解其作用机制(MOA)。在这方面,人源化免疫系统(HIS)模型是有价值的工具。然而,对HIS建模缺乏系统指导。为了解决这个问题,本研究旨在建立和优化多种免疫肿瘤学(IO)研究的HIS模型,包括基因工程小鼠模型和在严重免疫受损小鼠中重建人类免疫成分的HIS模型。根据其MOA,使用几种已上市或研究的IO药物测试了这些模型的功效和实用性,然后进行免疫表型分析和疗效评价。本研究的结果表明,HIS模型对各种IO药物的反应符合预期,并且每个模型都有独特的生态位,公用事业和限制。研究人员应根据MOA和研究药物的靶向免疫细胞群体仔细选择合适的模型。本研究提供了有价值的方法和可操作的技术指导,生成或利用适当的HIS模型来解决翻译IO中的特定问题。
    The field of cancer immunotherapy has experienced significant progress, resulting in the emergence of numerous biological drug candidates requiring in vivo efficacy testing and a better understanding of their mechanism of action (MOA). Humanized immune system (HIS) models are valuable tools in this regard. However, there is a lack of systematic guidance on HIS modeling. To address this issue, the present study aimed to establish and optimize a variety of HIS models for immune-oncology (IO) study, including genetically engineered mouse models and HIS models with human immune components reconstituted in severely immunocompromised mice. The efficacy and utility of these models were tested with several marketed or investigational IO drugs according to their MOA, followed by immunophenotypic analysis and efficacy evaluation. The results of the present study demonstrated that the HIS models responded to various IO drugs as expected and that each model had unique niches, utilities and limitations. Researchers should carefully choose the appropriate models based on the MOA and the targeted immune cell populations of the investigational drug. The present study provides valuable methodologies and actionable technical guidance on designing, generating or utilizing appropriate HIS models to address specific questions in translational IO.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在漫长的进化过程中,植物已经发展了自我保护机制,比如留下种子,落叶,越来越多的荆棘,产生特定物质或发出特殊气味以驱除昆虫。尽管对分类学特征的研究,棘在多刺植物中的作用和应用在国内外已有报道,目前缺乏对植物棘的系统概述。因此,本研究根据国内外对植物棘的研究,确定了植物棘的特征和类型,为确定植物棘的类型提供了明确的标准或依据。此外,功能,监管机制,阐述和总结了影响棘突形成的因素及其开发和应用前景。这项研究将有助于提高对类型的理解,植物刺的功能和调控机制,为植物从刺变种到非刺变种的遗传改良提供新的思路。
    Over a long period of evolution, plants have developed self-protection mechanisms, such as leaving seeds, dropping leaves, growing thorns, producing specific substances or emitting special odors to repel insects. Although studies on the taxonomic characteristics, functions and application of spines in spiny plants have been reported in China and abroad, a systematic overview of plant spines is currently lacking. This study therefore identifies the characteristics and types of plant spines based on domestic and international research on plant spines to provide clear criteria or bases for determining the types of plant spines. In addition, the functions, regulatory mechanisms, and factors influencing the formation of spines and the prospects for their development and application are described and summarized. This study will help to improve the understanding of the types, functions and regulatory mechanisms of plant spines and provide new ideas for the genetic improvement of plants from spiny to nonspiny varieties.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    未经评估:耐多药结核病(MDR-TB)的治疗和病例管理是结核病(TB)控制和预防的重大挑战。这项试点研究旨在应用和测试一种新的电子信息系统,以帮助加强耐多药结核病的病例管理。
    UNASSIGNED:MDR-TB病例管理系统(CMS)于2017年在云南省结核病临床中心(TCC)开发并试点。接下来,2018年随机抽取云南5个站点作为试点。计算了试点地区的实时定期随访率(RFUR)。通过卡方检验比较了中试和非中试地点之间的MDR-TB治疗队列的随访丢失率(LTFU)。然后通过单变量和多变量二元逻辑回归评估MDR-TB治疗队列的LTFU。
    UNASSIGNED:TCC的平均定期随访率分别为90.7%和云南省其他五个试点的73.7%。试点地区的平均LTFU率(9.0%)低于非试点地区(20.6%,P<0.01)。与非试点病例相比,CMS试点病例在MDR-TB治疗期间LTFU的风险降低了61.7%(调整后比值比:0.38,95%置信区间:0.23-0.60)。
    UNASSIGNED:作为结核病信息管理系统的重要补充,CMS加强了收集,分析,以及利用耐多药结核病病例的战略信息。该系统通过将其嵌入为综合支持护理服务模型的工具来改进案例管理。
    UNASSIGNED: Treatment and case management of multidrug-resistant tuberculosis (MDR-TB) is a significant challenge in tuberculosis (TB) control and prevention. This pilot study aims to apply and test a new electronic information system in order to help bolster case management of MDR-TB.
    UNASSIGNED: The MDR-TB Case Management System (CMS) was developed and piloted in the Yunnan Tuberculosis Clinical Center (TCC) in 2017. Next, 5 sites in Yunnan were randomly selected and sampled as pilots in 2018. The real-time regular follow-up rate (RFUR) was calculated for pilot sites. Loss to follow-up (LTFU) rates of MDR-TB treatment cohorts between pilot and non-pilot sites were compared by a chi-square test. LTFU for MDR-TB treatment cohorts was then assessed by univariate and multivariate binary logistic regression.
    UNASSIGNED: The average regular follow-up rate was 90.7% in TCC and 73.7% in five other pilot sites of Yunnan Province respectively. The average LTFU rate for pilot sites (9.0%) was lower than non-pilot sites (20.6%, P<0.01). The risk of LTFU during MDR-TB treatment reduced 61.7% in CMS pilot cases (adjusted odds ratio: 0.38, 95% confidence interval: 0.23-0.60) compared with non-pilot cases.
    UNASSIGNED: As a significant supplement to the Tuberculosis Information Management System, the CMS strengthened the collection, analysis, and utilization of strategic information for MDR-TB cases. The system improved case management by embedding it as a tool of the Comprehensive Supportive Care service model.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    The present study reviewed the relevant recent literature regarding the development and application of oblique lumbar interbody fusion (OLIF), with a particular focus on its application and associated complications. The study evaluated the rationality of this technique and demonstrated the direction of future research by collecting data on previous operative outcomes and complications. A literature search was performed in Pubmed and Web of Science, including the following keywords and abbreviations: anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), direct lateral interbody fusion (DLIF), extreme lateral interbody fusion (XLIF), oblique lateral interbody fusion (OLIF), adjacent segment disease (ASD), and adult degenerative scoliosis (ADS). A search of literature published from January 2005 to January 2019 was conducted and all studies evaluating development and application of OLIF were included in the review. According to the literature, the indications for OLIF are various. OLIF has excellent orthopaedic effects in degenerative scoliosis patients and the incidence of bony fusion is higher than for other approaches. It also provides a better choice for revision surgery. It has various advantages in many aspects, but the complications cannot be ignored. As a new minimally invasive technique, the advantages of OLIF are obvious, but further evaluation is needed to compare its operation-related data with that of traditional open surgery. In addition, more prospective studies are required to compare minimally invasive and open spinal surgery to confirm its specific efficacy, risk, advantages, learning curve, and ultimate clinical efficacy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号